Which compound has more published research data available?# Tirzepatide has substantially more published research data as of 2026 because it entered clinical development earlier and has a larger completed trial program across the SURPASS and SURMOUNT study families covering type 2 diabetes, obesity, sleep-disordered breathing, and cardiometabolic endpoints
GLP-1RAs are being studied for their significant associations with reduced risks of various cardiovascular diseases, neuropsychiatric or substance use disorders, infectious illnesses and respiratory conditions, indicating their potential for broader therapeutic applications [111]
,
But in reality, this high-touch, expert support is what makes coverage a good, long-term investment
7 The GLP-1 receptor (GLP-1R) is a G protein-coupled receptor that, when activated, triggers complex intracellular signaling cascades
Cells were treated with the primary antibody overnight at 4C and followed by secondary antibodies (ZSGB-BIO) in the dark at room temperature for 1 h
